Polypeptide formulation
First Claim
Patent Images
1. A pharmaceutical composition that is a stable aqueous formulation comprising an Fc domain containing polypeptide and an aggregation inhibitor, wherein the aggregation inhibitor is L-arginine.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to an aqueous pharmaceutical composition suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin, methods of manufacture, methods of administration and kits containing same.
155 Citations
30 Claims
- 1. A pharmaceutical composition that is a stable aqueous formulation comprising an Fc domain containing polypeptide and an aggregation inhibitor, wherein the aggregation inhibitor is L-arginine.
-
13. A stable pharmaceutical composition comprising about 10 mg/ml to about 100 mg/ml TNFR:
- Fc, L-arginine, sodium phosphate, sodium chloride and sucrose.
- View Dependent Claims (14, 15, 16, 17, 18, 19, 29)
-
22. A method of formulating a composition comprising combining isolated TNFR:
- Fc with L-arginine.
- View Dependent Claims (23, 24)
- 25. A kit comprising a composition comprising an Fc domain containing polypeptide and L-arginine, and instructions for use of said composition.
-
30. A method of accelerated stability testing of an Fc domain containing polypeptide in a pharmaceutical composition, wherein the composition comprises L-arginine, the steps of the method comprising storing the composition at 37°
- C. and measuring the stability of the polypeptide after at least one month at 37°
C.
- C. and measuring the stability of the polypeptide after at least one month at 37°
Specification